$Recro制药(REPH)$ 内部交易: 2021-12-15,CEO,ENLOE J DAVID JR ,买入,617普通股, $1.61
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-048869 Size: 4 KB 网页链接
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-048870 Size: 4 KB 网页链接
$Recro制药(REPH)$ 内部交易: 2021-12-15,10% Owner,AWM Investment Company, Inc. ,卖出,20000普通股, $1.63
$Recro制药(REPH)$ 内部交易: 2021-12-14,10% Owner,AWM Investment Company, Inc. ,卖出,10602普通股, $1.57
$Recro制药(REPH)$ 内部交易: 2021-12-13,10% Owner,AWM Investment Company, Inc. ,卖出,20000普通股, $1.63
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001535264-21-000051 Size: 9 KB 网页链接
$Recro制药(REPH)$ 内部交易: 2021-11-17,Director,Miller James Charles ,买入,1000普通股, $1.69
$Recro制药(REPH)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000899243-21-045409 Size: 4 KB 网页链接
$Recro制药(REPH)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001535264-21-000047 Size: 5 KB 网页链接